Esperion Therapeutics, Inc. (ESPR)
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
Address
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI 48108
Founded
1998
Number of Employees
240
Website
http://www.esperion.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)